Search Results - Henning Wege
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
-
2
Treatment Lines in Hepatocellular Carcinoma by Henning Wege, Jun Li, Harald Ittrich
Published 2019Revisão -
3
The Diagnosis and Treatment of Cholangiocarcinoma by Arndt Vogel, Henning Wege, Karel Caca, Björn Nashan, Ulf P. Neumann
Published 2014Revisão -
4
-
5
Presence of EpCAM‐positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma by Kornelius Schulze, Christin Gasch, Katharina Staufer, Björn Nashan, Ansgar W. Lohse, Klaus Pantel, Sabine Riethdorf, Henning Wege
Published 2013Artigo -
6
-
7
-
8
-
9
Aurora Kinase Inhibitor PHA-739358 Suppresses Growth of Hepatocellular Carcinoma In Vitro and in a Xenograft Mouse Model by Daniel Benten, Gunhild Keller, Alexander Quaas, Jörg Schrader, Artur Gontarewicz, Stefan Balabanov, Melanie Braig, Henning Wege, Jürgen Moll, Ansgar W. Lohse, Tim H. Brümmendorf
Published 2009Artigo -
10
Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential by Henning Wege, Hai Thanh Le, Michael S. Chui, Li Liu, Jian Wu, Ranjit K. Giri, Harmeet Malhi, Baljit S. Sappal, Vinay Kumaran, Sanjeev Gupta, Mark Α. Zern
Published 2003Artigo -
11
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICC... by Alexander Stein, Dirk Arnold, John Bridgewater, David Goldstein, Lars Henrik Jensen, Heinz‐Josef Klümpen, Ansgar W. Lohse, Björn Nashan, John Primrose, Silke Schrum, Jenny Shannon, Eik Vettorazzi, Henning Wege
Published 2015Artigo -
12
Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials by Changhoon Yoo, Anna Saborowski, Jaewon Hyung, Patrick Wenzel, Il Hwan Kim, Henning Wege, Kyu‐pyo Kim, Gunnar Folprecht, Baek‐Yeol Ryoo, Phillip Schütt, Jaekyung Cheon, Thorsten Oliver Goetze, Hyewon Ryu, Ji Sung Lee, Arndt Vogel
Published 2025Artigo -
13
Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-Derived Erythropoietin and Anemia by Mila Rivkin, Alina Simerzin, Elina Zorde‐Khvalevsky, Chofit Chai, Jonathan B. Yuval, Nofar Rosenberg, Rona Harari-Steinfeld, Ronen Schneider, Gail Amir, Reba Condiotti, Mathias Heikenwälder, Achim Weber, Christoph Schramm, Henning Wege, Johannes Kluwe, Eithan Galun, Hilla Giladi
Published 2016Artigo -
14
Programmed cell death protein‐1 (<scp>PD</scp>‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world... by Bernhard Scheiner, Martha M. Kirstein, Florian Hucke, Fabian Finkelmeier, Kornelius Schulze, Johann von Felden, Sandra Koch, Philipp Schwabl, Jan B. Hinrichs, Fredrik Waneck, Oliver Waidmann, Thomas Reiberger, Christian Müller, Wolfgang Sieghart, Michael Trauner, Arndt Weinmann, Henning Wege, Jörg Trojan, Markus Peck‐Radosavljevic, Arndt Vogel, Matthias Pinter
Published 2019Artigo -
15
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort by Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, Jan Best, Thorben Fründt, Carolin Czauderna, Alica K. Beutel, Dominik Bettinger, Johannes Weiß, Tobias Meischl, Fabian Kütting, Dirk‐Thomas Waldschmidt, Pompilia Radu, Michael Schultheiß, Kai‐Henrik Peiffer, Thomas Jens Ettrich, Arndt Weinmann, Henning Wege, Marino Venerito, Jean‐François Dufour, Christian M. Lange, Matthias Pinter, Oliver Waidmann
Published 2021Artigo -
16
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis by Felix Stickel, Stephan Buch, Hans Dieter Nischalke, Karl Heinz Weiss, Daniel Gotthardt, Janett Fischer, Jonas Rosendahl, Astrid Marot, Mona Elamly, Markus Casper, Frank Lammert, Andrew McQuillin, Steffen Zopf, Ulrich Spengler, Silke Marhenke, Martha M. Kirstein, Arndt Vogel, Florian Eyer, Johann von Felden, Henning Wege, Thorsten Buch, Clemens Schafmayer, Felix Braun, Pierre Deltenre, Thomas Berg, Marsha Y. Morgan, Jochen Hampe
Published 2018Artigo -
17
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study by Sabrina Welland, Catherine Leyh, Fabian Finkelmeier, André Jefremow, Kateryna Shmanko, Maria A. González-Carmona, Arne Kandulski, Petia Jeliazkova, Jan Best, Thorben Fründt, Angela Djanani, Maria Pangerl, A Maieron, Richard Greil, Christina Fricke, Disorn Sookthai, Rainer Günther, Andreas Schmiderer, Henning Wege, Marino Venerito, Ursula Ehmer, Martina Müller, Christian P. Strassburg, Arndt Weinmann, Jürgen Siebler, Oliver Waidmann, Christian M. Lange, Anna Saborowski, Arndt Vogel
Published 2022Artigo -
18
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis by Jan Best, Lars P. Bechmann, Jan‐Peter Sowa, Svenja Sydor, Alexander Dechêne, Kristina Pflanz, Sotiria Bedreli, Clemens Schotten, Andreas Geier, Thomas Berg, Janett Fischer, Arndt Vogel, Heike Bantel, Arndt Weinmann, Jörn M. Schattenberg, Yvonne Huber, Henning Wege, Johann von Felden, Kornelius Schulze, Dominik Bettinger, Robert Thimme, Friedrich Sinner, Kerstin Schütte, Karl Heinz Weiss, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Sarah Berhane, Marc Wichert, Dominik Heider, Guido Gerken, Philip J. Johnson, Ali Canbay
Published 2019Artigo -
19
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study by Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Vincent E. Gaillard, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Y. Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei‐Chang Lee, Yi‐Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Nicola Personeni, Tiziana Pressiani, Rohini Sharma, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato
Published 2022Artigo -
20
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma by Mathew Vithayathil, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Y. Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei‐Chang Lee, Yi‐Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Nicola Personeni, Tiziana Pressiani, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato, Rohini Sharma
Published 2022Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Hepatocellular carcinoma
Oncology
Cancer
Gastroenterology
Biology
Chemotherapy
Immunotherapy
Biochemistry
Cohort
Adverse effect
Bevacizumab
Atezolizumab
Cirrhosis
Disease
Nivolumab
Sorafenib
Liver cancer
Molecular biology
Cell biology
Chemistry
Gene
Immunology
Pathology
Surgery
Cancer research
Clinical trial
Confidence interval
Gemcitabine